Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Glycobiology Market – Insights

The term glycobiology is a branch of biology that deals with study of structure, function, and biosynthesis of saccharides (carbohydrates and carbohydrates containing molecules). Glycoconjugates is the general classification for carbohydrates covalently linked with other chemical species such as proteins, peptides, lipids and saccharides. Glycoconjugates and polysaccharides play a vital structural role in connective tissues.

The global glycobiology market is estimated to account for US$ 1,007.4 Mn in terms of value in 2020 and is expected to reach US$ 2,397.5 Mn by the end of 2027.

Global Glycobiology Market: Drivers

Glycans impact tumor proliferation, hematogenous metastasis, invasion and angiogenesis. Therefore, increasing prevalence of cancer is expected to propel growth of the global glycobiology market over the forecast period. For instance, according to the World Health Organization, around 18.1 million new cases and 9.6 million deaths were registered due to cancer worldwide in 2018.

Moreover, high incidence of HIV/AIDS is also expected to aid in growth of the market. For instance, according to Joint United Nations Program on HIV/AIDS, 37.9 million people globally were living with HIV at the end of 2018.   

North America region held dominant position in the global glycobiology market in 2018, accounting for 44.3% share in terms of value, followed by Europe.

Glycobiology  | Coherent Market Insights

Global Glycobiology Market: Restraints

Complex structure of glycans is expected to hinder growth of the global glycobiology market.  Unlike DNA or proteins, glycans do not have linear structure. Conventional sequence comparison methods cannot be applied directly to glycan comparison as structure and mechanism of glycans are completely different from DNA or proteins, which makes it more complex for analyzing. DNA or proteins have template sequences to synthesize primary structure, which are uniquely identified by template sequences. However, glycans do not have a template structure. Structure of glycan is determined by substrate specificity of glycosyl-transferases.

Moreover, high costs of spectrometry and high performance liquid chromatography are also expected to limit growth of the market.

Global Glycobiology Market: Opportunities 

R&D in glycans is expected to offer lucrative growth opportunities for players in the global glycobiology market. For instance, in February 2020, researchers from University of Minho, Portugal, reported development of a neurocompatible strategy to image temporal distribution of glycoproteins during neuronal development using Cu-free click chemistry.

Moreover, increasing focus on manufacturing anti-cancer drugs is also expected to aid in growth of the market. For instance, in January 2020, researchers from Universidade do Porto, Portugal, reported assessment of the role of O-glycosylation using glycoengineered gastric cancer models in the detection of CD44v9 – a major protein splice variant isoforms expressed in human gastrointestinal cancer cells—by monoclonal antibodies. 

Enzymes segment in the global glycobiology market was valued at US$ 487.1 Mn in 2019 and is expected to reach US$ 1,371.0 Mn by 2027 at a CAGR of 13.6% during the forecast period.

Market Trends/Key Takeaways

Increasing adoption of viscosupplementation and facial aesthetic using hyaluronic acid is aiding growth of the market. Hyaluronan, a natural occurring glycosaminogen, is used in viscosupplementation and tissue fillers for volume restoration in facial rejuvenation.

Replacement of conventional glycoanalysis approaches with advanced techniques is also boosting growth of the market. Conventional methods for analysis of glycoforms in complex glycoproteins such as gel electrophoresis and elemental analysis are rapidly getting replaced by new approaches such as nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS).

Glycobiology  | Coherent Market Insights

Global Glycobiology Market: Competitive Landscape

Major players operating in the global glycobiology market include, Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Plexera Bioscience LLC, New England Biolabs Inc., Agilent Technologies, Inc., and ProZyme, Inc.

Global Glycobiology Market: Key Developments

Major players in the market are focused on adopting various marketing strategies to expand their customer base. For instance, in February 2020, New England Biolabs demonstrated its next generation sequencing portfolio at 2020 Advances in Genome Biology and Technology (AGBT) General Meeting, held in the U.S.

Players in the market are also focused on adopting partnership strategies to expand their product portfolio. For instance, in November 2019, MOBILion Systems, Inc. partnered with researchers at the University of Georgia, for R&D in glycans and glycoproteins.

Glycobiology involves study of structural aspects, biosynthesis, and biology of polysaccharides and how they function in an organism. Study of glycobiology has variety of application in areas such as drug discovery and development, diagnostic applications, therapeutic application, and industrial applications.

Restraints of the Global Glycobiology Market

Complex structure of glycan’s and difficulty in its study, high costs of spectrometry and high performance liquid chromatography are expected to hinder growth of the market.

Key features of the study:

  • This report provides in-depth analysis of the global glycobiology market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global glycobiology market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Merck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Plexera Bioscience LLC, New England Biolabs Inc., Agilent Technologies, Inc., and ProZyme, Inc.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global glycobiology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Glycobiology Market, By Product Type:
    • Instruments
    • Enzymes
    • Consumables
    • Reagents & Kits
  • Global Glycobiology Market, By Enzymes:
    • Galactosidase
      • Fucosidases
      • Chitinases
      • Acetylgalactosaminidase
      • Heparinase
      • PNGase F
      • Others
    • GlcNAc Transferases
      • Acetylglucosaminyltransferase
      • Exostosin
      • Others
    • Fucosyltransferases
    • GalNAc Transferases
    • Galactosyl Transferases
    • Glucuronosyltransferases
    • Glucosyltransferases
    • Pentosyltransferases
    • Carbohydrate Kinases
    • Neuraminidases
    • Sialyltransferases
    • Others
  • Global Glycobiology Market, By Application:
    • Drug Discovery and Development
    • Diagnostic Applications
      • Oncology
      • Immunology
      • Others
    • Industrial Application
    • Therapeutic Application
      • Oncology
      • Immunology
      • Others
    • Others
  • Global Glycobiology Market, By End User:
    • Biopharmaceutical Companies
    • Research Laboratories
    • Hospitals
    • Diagnostic Centers
    • Contract Research Organizations
    • Biotechnology Industries
    • Academic Institutes
    • Others
  • Global Glycobiology Market, By Geography:
    • North America
      • By Product Type
        • Instruments
        • Enzymes
        • Consumables
        • Reagents & Kits
      • By Enzymes
        • Galactosidases
          • Fucosidases
          • Chitinases
          • Acetylgalactosaminidase
          • Heparinase
          • PNGase F
          • Others
        • GlcNAc Transferases
          • Acetylglucosaminyltransferase
          • Exostosin
          • Others
        • Fucosyltransferases
        • GalNAc Transferases
        • Galactosyl Transferases
        • Glucuronosyltransferases
        • Glucosyltransferases
        • Pentosyltransferases
        • Carbohydrate Kinases
        • Neuraminidases
        • Sialyltransferases
        • Others
      • By Application
        • Drug Discovery and Development
        • Diagnostic Applications
          • Oncology
          • Immunology
          • Others
        • Industrial Application
        • Therapeutic Application
          • Oncology
          • Immunology
          • Others
          • Others
      • By End User
        • Biopharmaceutical Companies
        • Research Laboratories
        • Hospitals
        • Diagnostic Centers
        • Contract Research Organizations
        • Biotechnology Industries
        • Academic Institutes
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type
        • Instruments
        • Enzymes
        • Consumables
        • Reagents & Kits
      • By Enzymes
        • Galactosidases
          • Fucosidases
          • Chitinases
          • Acetylgalactosaminidase
          • Heparinase
          • PNGase F
          • Others
        • GlcNAc Transferases
          • Acetylglucosaminyltransferase
          • Exostosin
          • Others
        • Fucosyltransferases
        • GalNAc Transferases
        • Galactosyl Transferases
        • Glucuronosyltransferases
        • Glucosyltransferases
        • Pentosyltransferases
        • Carbohydrate Kinases
        • Neuraminidases
        • Sialyltransferases
        • Others
      • By Application
        • Drug Discovery and Development
        • Diagnostic Applications
          • Oncology
          • Immunology
          • Others
        • Industrial Application
        • Therapeutic Application
          • Oncology
          • Immunology
          • Others
          • Others
      • By End User
        • Biopharmaceutical Companies
        • Research Laboratories
        • Hospitals
        • Diagnostic Centers
        • Contract Research Organizations
        • Biotechnology Industries
        • Academic Institutes
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Instruments
        • Enzymes
        • Consumables
        • Reagents & Kits
      • By Enzymes
        • Galactosidases
          • Fucosidases
          • Chitinases
          • Acetylgalactosaminidase
          • Heparinase
          • PNGase F
          • Others
        • GlcNAc Transferases
          • Acetylglucosaminyltransferase
          • Exostosin
          • Others
        • Fucosyltransferases
        • GalNAc Transferases
        • Galactosyl Transferases
        • Glucuronosyltransferases
        • Glucosyltransferases
        • Pentosyltransferases
        • Carbohydrate Kinases
        • Neuraminidases
        • Sialyltransferases
        • Others
      • By Application
        • Drug Discovery and Development
        • Diagnostic Applications
          • Oncology
          • Immunology
          • Others
        • Industrial Application
        • Therapeutic Application
          • Oncology
          • Immunology
          • Others
      • By End User
        • Biopharmaceutical Companies
        • Research Laboratories
        • Hospitals
        • Diagnostic Centers
        • Contract Research Organizations
        • Biotechnology Industries
        • Academic Institutes
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type
        • Instruments
        • Enzymes
        • Consumables
        • Reagents & Kits
      • By Enzymes
        • Galactosidases
          • Fucosidases
          • Chitinases
          • Acetylgalactosaminidase
          • Heparinase
          • PNGase F
          • Others
        • GlcNAc Transferases
          • Acetylglucosaminyltransferase
          • Exostosin
          • Others
        • Fucosyltransferases
        • GalNAc Transferases
        • Galactosyl Transferases
        • Glucuronosyltransferases
        • Glucosyltransferases
        • Pentosyltransferases
        • Carbohydrate Kinases
        • Neuraminidases
        • Sialyltransferases
        • Others
      • By Application
        • Drug Discovery and Development
        • Diagnostic Applications
          • Oncology
          • Immunology
          • Others
        • Industrial Application
        • Therapeutic Application
          • Oncology
          • Immunology
          • Others
      • By End User
        • Biopharmaceutical Companies
        • Research Laboratories
        • Hospitals
        • Diagnostic Centers
        • Contract Research Organizations
        • Biotechnology Industries
        • Academic Institutes
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • By Product Type
        • Instruments
        • Enzymes
        • Consumables
        • Reagents & Kits
      • By Enzymes
        • Galactosidases
          • Fucosidases
          • Chitinases
          • Acetylgalactosaminidase
          • Heparinase
          • PNGase F
          • Others
        • GlcNAc Transferases
          • Acetylglucosaminyltransferase
          • Exostosin
          • Others
        • Fucosyltransferases
        • GalNAc Transferases
        • Galactosyl Transferases
        • Glucuronosyltransferases
        • Glucosyltransferases
        • Pentosyltransferases
        • Carbohydrate Kinases
        • Neuraminidases
        • Sialyltransferases
        • Others
      • By Application
        • Drug Discovery and Development
        • Diagnostic Applications
          • Oncology
          • Immunology
          • Others
        • Industrial Application
        • Therapeutic Application
          • Oncology
          • Immunology
          • Others
      • By End User
        • Biopharmaceutical Companies
        • Research Laboratories
        • Hospitals
        • Diagnostic Centers
        • Contract Research Organizations
        • Biotechnology Industries
        • Academic Institutes
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Instruments
        • Enzymes
        • Consumables
        • Reagents & Kits
      • By Enzymes
        • Galactosidases
          • Fucosidases
          • Chitinases
          • Acetylgalactosaminidase
          • Heparinase
          • PNGase F
          • Others
        • GlcNAc Transferases
          • Acetylglucosaminyltransferase
          • Exostosin
          • Others
        • Fucosyltransferases
        • GalNAc Transferases
        • Galactosyl Transferases
        • Glucuronosyltransferases
        • Glucosyltransferases
        • Pentosyltransferases
        • Carbohydrate Kinases
        • Neuraminidases
        • Sialyltransferases
        • Others
      • By Application
        • Drug Discovery and Development
        • Diagnostic Applications
          • Oncology
          • Immunology
          • Others
        • Industrial Application
        • Therapeutic Application
          • Oncology
          • Immunology
          • Others
      • By End User
        • Biopharmaceutical Companies
        • Research Laboratories
        • Hospitals
        • Diagnostic Centers
        • Contract Research Organizations
        • Biotechnology Industries
        • Academic Institutes
        • Others
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Key Strategies
    • Recent Developments
    • Merck KGaA *
    • Bio-Techne Corporation
    • Bruker Corporation
    • Thermo Fisher Scientific, Inc.
    • Shimadzu Corporation
    • Plexera Bioscience LLC
    • New England Biolabs Inc.
    • Agilent Technologies, Inc.
    • ProZyme, Inc.

 “*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Enzyme
      • Market Snippet, By Application
      • Market Snippet, By End User
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Regulatory Scenario
    • PEST Analysis
  4. Global Glycobiology Market, By Product Type, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Instruments
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Enzymes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Consumables
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
    • Reagents & Kits
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Glycobiology Market, By Enzymes, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Galactosidase
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Fucosidases
        • Chitinases
        • Acetylgalactosaminidase
        • Heparinase
        • PNGase F
        • Others
    • GlcNAc Transferases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Acetylglucosaminyltransferase
        • Exostosin
        • Others
    • Fucosyltransferases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • GalNAc Transferases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Galactosyl Transferases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Glucuronosyltransferases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Glucosyltransferases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Pentosyltransferases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Carbohydrate Kinases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Neuraminidases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Sialyltransferases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Global Glycobiology Market, By Application, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Drug Discovery and Development
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diagnostic Applications
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Oncology
        • Immunology
        • Others
    • Industrial Application
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Therapeutic Application
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Oncology
        • Immunology
        • Others
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Global Glycobiology Market, By End User, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • Biopharmaceutical Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Research Laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Diagnostic Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Contract Research Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Biotechnology Industries
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Academic Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Global Glycobiology Market, By Regions, 2019 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape
    • Company Profiles
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bio-Techne Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Bruker Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Thermo Fisher Scientific, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Shimadzu Corporation
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Plexera Bioscience LLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • New England Biolabs Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Agilent Technologies, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • ProZyme, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 39 market data tables and 47 figures on “Glycobiology Market – Global forecast to 2027.

Frequently Asked Questions

The global glycobiology market is estimated to reach US$ 2,397.5 Mn by the end of 2027.
Major players operating in the global glycobiology market includeMerck KGaA, Bio-Techne Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Plexera Bioscience LLC, New England Biolabs Inc., Agilent Technologies, Inc., and ProZyme, Inc.
Complex structure of glycansis one of the major factors that is expected to hamper growth of the market over the forecast period.
Increasing prevalence of cancer is one of the major factors that is expected to propel growth of the market over the forecast period.
Increasing adoption of viscosupplementation and facial aesthetic using hyaluronic acid is one of the major trends that has been observed in the market.
Among regions, North America held a dominant position in the global glycobiology market in 2018, accounting for 44.3% share in terms of value, followed by Europe.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner